Suchergebnisse - "Motoi, Noriko"

PubPharm (7)

1

Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients

enthalten in: Anticancer research | 2021

von Shimoda, Y. | Yoshida, T. | Shirasawa, M. | +11

2

Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab : a single-institution retrospective study

enthalten in: Melanoma research | 2020

von Namikawa, K. | Takahashi, A. | Mori, T. | +9

3

A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non-Small Cell Lung Carcinoma

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2019

von Naito, T. | Udagawa, H. | Sato, J. | +15

4

Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden : A case report

enthalten in: Thoracic cancer | 2019

von Naito, T. | Umemura, S. | Nakamura, H. | +11

5

Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer

enthalten in: Thoracic cancer | 2019

von Shibaki, R. | Murakami, S. | Shinno, Y. | +8

6

Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Sekine, K. | Kanda, S. | Goto, Y. | +5

7

Programmed Death-Ligand 1 Immunohistochemistry Testing : A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Büttner, R. | Gosney, J. | Skov, B. | +11

CommentIn: J Thorac Dis. 2018 Mar;10 (3):1217-1219. - PMID 29708172

1
[1]